Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

Peripheral Vascular Devices Market Summary

Overview:

• The Peripheral Vascular Devices market is estimated at USD 10.44 billion in 2025 and is projected to reach USD 17.5 billion by 2034. Growth is anchored in the rising global burden of peripheral artery disease and venous thromboembolism, an aging population, the growing diabetic and at-risk population, and continued innovation in drug-eluting and minimally invasive endovascular devices.
• The global Peripheral Vascular Devices market is growing at a CAGR of 5.92% during the forecast period from 2026 to 2034.
• By product type, the percutaneous transluminal angioplasty balloon catheters segment dominated the Peripheral Vascular Devices market with a 34% share in 2025.
• By application, the peripheral artery disease segment dominated the Peripheral Vascular Devices market with a share of 62% in 2025.
• By end user, the hospitals segment dominated the Peripheral Vascular Devices market with a share of 68% in 2025.
• North America dominated the global Peripheral Vascular Devices market revenue with a share of 41% in 2025, representing the highest regional market share globally.

Peripheral vascular devices are medical devices used to diagnose and treat diseases of the blood vessels outside the heart and brain, primarily the arteries and veins of the legs, arms, kidneys, and pelvis. The category spans percutaneous transluminal angioplasty balloon catheters, including drug-eluting, cutting, and scoring balloon catheters; angioplasty stents, including drug-eluting stents, bare-metal stents, and expandable stents; plaque modification devices, including atherectomy and thrombectomy devices; hemodynamic flow alteration devices, including embolic protection devices and chronic total occlusion devices; inferior vena cava filters, in retrievable and permanent forms; and other peripheral vascular devices. These devices are used to treat peripheral artery disease, deep vein thrombosis and venous thromboembolism, pulmonary embolism, and other peripheral vascular conditions, and are used across hospitals, specialty and ambulatory centers, and other settings. The market is served by major manufacturers including Medtronic, Boston Scientific, Abbott, Becton Dickinson through its Bard peripheral vascular business, Cook Medical, B. Braun, W. L. Gore and Associates, Terumo, AngioDynamics, and LeMaitre Vascular. Over the past decade, the field has advanced from plain balloon angioplasty and bare-metal stents toward drug-coated balloons, drug-eluting stents, advanced atherectomy and thrombectomy systems, and refined chronic total occlusion and embolic protection technologies. Driven by the large and rising burden of peripheral vascular disease, an aging and diabetic population, and continued device innovation, the peripheral vascular devices market is a large and steadily growing segment of the cardiovascular and endovascular device industry.

Peripheral Vascular Devices Market Key Growth Drivers

• The large and rising global burden of peripheral artery disease, affecting a growing population worldwide, is expanding demand for peripheral vascular devices.
• The aging global population, with its higher prevalence of atherosclerosis and peripheral vascular disease, is broadening the patient base.
• The growing diabetic, hypertensive, obese, and smoking populations, all major risk factors for peripheral vascular disease, are increasing disease incidence.
• Continued innovation in drug-coated balloons, drug-eluting stents, and advanced atherectomy and thrombectomy systems is improving outcomes and expanding treatment options.
• The shift toward minimally invasive endovascular procedures over open surgery is increasing the adoption of peripheral vascular devices.
• The rising burden of venous thromboembolism, deep vein thrombosis, and pulmonary embolism is expanding demand for thrombectomy devices and inferior vena cava filters.
• The convergence of rising disease burden, an aging and at-risk population, and device innovation is expected to sustain steady growth in the global Peripheral Vascular Devices market through 2034.

Key Companies in Peripheral Vascular Devices Market

The competitive landscape is led by the following active manufacturers of peripheral vascular devices:

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Cook Group Incorporated (Cook Medical)
• B. Braun SE
• W. L. Gore & Associates, Inc.
• Terumo Corporation
• AngioDynamics, Inc.
• LeMaitre Vascular, Inc.

Factors Contributing to the Growth of the Peripheral Vascular Devices Market

Market Drivers

Large and Rising Burden of Peripheral Artery Disease

The large and rising global burden of peripheral artery disease is the foundational driver of the peripheral vascular devices market. Peripheral artery disease, caused by atherosclerotic narrowing of the arteries supplying the limbs, affects a large and growing population worldwide, with hundreds of millions of people estimated to be affected globally, and its prevalence rises sharply with age and with the growth of diabetes, hypertension, obesity, and smoking. The condition causes claudication, critical limb ischemia, and the risk of amputation, and endovascular treatment with balloon angioplasty, stents, and atherectomy is central to its management. The large and underdiagnosed population with peripheral artery disease, together with growing awareness and diagnosis, represents a substantial and expanding addressable market. As the burden of peripheral artery disease continues to rise with aging and risk-factor prevalence, demand for peripheral vascular devices is expected to grow, reinforcing sustained market growth throughout the forecast period.

Aging Global Population

The aging global population is a substantial driver of the market. The prevalence of atherosclerosis, peripheral artery disease, venous disease, and related vascular conditions rises steeply with age, and the global population aged sixty-five and older is growing rapidly across both developed and developing regions. Older patients experience higher rates of peripheral vascular disease, critical limb ischemia, and venous thromboembolism, and are increasingly treated with minimally invasive endovascular devices that offer lower procedural risk than open surgery for this often frail population. The expanding elderly population directly enlarges the patient base for peripheral vascular devices across arterial and venous indications. As the global population continues to age, the rising prevalence of age-related vascular disease is expected to be an important driver of market growth across the forecast period.

Market Restraints

Despite strong growth potential, the Peripheral Vascular Devices market faces material constraints. The high cost of advanced devices such as drug-coated balloons, drug-eluting stents, and atherectomy and mechanical thrombectomy systems, together with constrained and variable reimbursement across health systems, limits access and pressures hospital budgets. Procedural risks and complications, including restenosis, distal embolization, vessel perforation, and the need for reintervention, temper adoption and require specialized expertise. Safety and efficacy scrutiny, including historical concerns about mortality signals associated with paclitaxel-coated devices in the femoropopliteal segment, has affected adoption patterns and regulatory oversight. Long and costly regulatory pathways for novel vascular devices, including Food and Drug Administration premarket approval and requirements under the European Medical Device Regulation, together with the need for robust long-term clinical evidence, slow commercialization. A shortage of trained interventionalists and vascular specialists in some regions constrains procedural capacity. Pricing pressure and competition in a consolidated market, where a few large manufacturers hold significant share, can compress margins. Finally, competition from pharmacological management, open surgery, and non-device therapies, together with uneven access in low-resource settings, constrains parts of the market across the forecast period.

Peripheral Vascular Devices Market Segment Analysis

The Peripheral Vascular Devices Market is segmented by product type (percutaneous transluminal angioplasty balloon catheters, angioplasty stents, plaque modification devices, hemodynamic flow alteration devices, inferior vena cava filters, others), application (peripheral artery disease, deep vein thrombosis and venous thromboembolism, pulmonary embolism, others), end user (hospitals, specialty centers, others), and geography (North America, Europe, Asia-Pacific, Rest of World).

By Product Type

Dominant Subsegment: Percutaneous Transluminal Angioplasty Balloon Catheters.

The percutaneous transluminal angioplasty balloon catheters segment accounted for 34% of the Peripheral Vascular Devices market in 2025. Balloon catheters dominate because balloon angioplasty is the foundational and highest-volume peripheral endovascular procedure, used across virtually all peripheral arterial interventions either as a standalone treatment or in combination with stenting and atherectomy. The segment includes drug-eluting, or drug-coated, balloon catheters such as Medtronic's IN. PACT Admiral and Boston Scientific's Ranger, PACT Admiral and Boston Scientific's Ranger, which deliver antiproliferative drug to reduce restenosis and have driven significant value growth, as well as cutting and scoring balloon catheters used to treat calcified and resistant lesions. The large procedure volumes, the premium value of drug-coated balloons, and continued innovation drive the largest share of the market. Angioplasty stents, including drug-eluting stents such as Eluvia and Zilver PTX, bare-metal stents, and expandable stents, represent a very large segment used to maintain vessel patency. Plaque modification devices, including atherectomy and thrombectomy devices; hemodynamic flow alteration devices, including embolic protection and chronic total occlusion devices; inferior vena cava filters, and other devices each represent important segments. Nonetheless, the high procedure volumes and premium drug-coated balloon value secure the leadership of the balloon catheter segment across the forecast period, with drug-eluting devices and mechanical thrombectomy growing rapidly.

By Application

Dominant Subsegment: Peripheral Artery Disease.

The peripheral artery disease segment accounted for 62% of the Peripheral Vascular Devices market in 2025. Peripheral artery disease dominates because it is the principal indication for peripheral vascular devices, affecting a large and growing population worldwide and driving the majority of peripheral endovascular procedures using balloon catheters, stents, atherectomy, and related devices. The large burden of peripheral artery disease, its rising prevalence with aging and diabetes, and the central role of endovascular treatment in managing claudication and critical limb ischemia drive the dominant share of the market. Deep vein thrombosis and venous thromboembolism represent a large and fast-growing application, driven by mechanical thrombectomy devices and inferior vena cava filters, and pulmonary embolism represents a rapidly growing application as large-bore mechanical thrombectomy systems expand adoption. Other applications, including renal, visceral, and arteriovenous access interventions, add further demand. Nonetheless, the large and rising burden of peripheral artery disease and its central role in peripheral intervention secure the leadership of this application across the forecast period, with venous and pulmonary embolism applications growing most rapidly.

Peripheral Vascular Devices Market Region Analysis

North America accounted for 41% of the global Peripheral Vascular Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high burden of peripheral artery disease and venous thromboembolism, advanced endovascular care infrastructure, high procedure volumes, early adoption of innovative devices, favorable reimbursement, and the presence of major manufacturers. The United States leads on the strength of a large population with peripheral vascular disease driven by high rates of diabetes, obesity, and an aging population, extensive catheterization laboratory and office-based laboratory infrastructure, early adoption of drug-coated balloons, drug-eluting stents, and mechanical thrombectomy, and the presence of companies such as Medtronic, Boston Scientific, Abbott, Becton Dickinson, and AngioDynamics. The regulatory environment is well established, with the Food and Drug Administration providing premarket approval and oversight pathways, and reimbursement supports both hospital and outpatient procedures. Strong clinical expertise, infrastructure, and early device adoption reinforce the market. This combination of disease burden, infrastructure, and innovation reinforces North America's leadership in the global market.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Peripheral Vascular Devices market. The region's elevated CAGR is driven by very large and aging populations, a rapidly rising burden of diabetes and peripheral vascular disease, expanding endovascular care access, and growing healthcare investment across China, India, Japan, and Southeast Asia. The region has among the world's largest and fastest-growing diabetic populations, a major risk factor for peripheral artery disease, and rising rates of atherosclerosis and venous thromboembolism, creating substantial and growing demand for peripheral vascular devices. Expanding catheterization laboratory infrastructure, growing numbers of trained interventionalists, rising healthcare spending, and increasing adoption of minimally invasive endovascular procedures broaden access. Both regional and multinational manufacturers are expanding their presence. The combination of large at-risk populations, rising disease burden, and expanding access positions Asia-Pacific as the highest-growth region over the forecast period.

Regional Commentary

North America

North America accounted for 41% of the global Peripheral Vascular Devices market revenue in 2025. The United States dominates the region on the strength of a high burden of peripheral vascular disease, extensive endovascular infrastructure, early adoption of advanced devices, favorable reimbursement, and the presence of major manufacturers, while Canada contributes through its vascular care system and Mexico expands access within its growing healthcare sector.

Europe

Europe represents a major regional market, led by Germany, France, the United Kingdom, Italy, and Spain, with strong endovascular care and the presence of manufacturers such as B. Braun and the European operations of global players. Growth is supported by an aging population and high disease burden, while the European Medical Device Regulation shapes product requirements and market access across the region.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by very large and aging populations, a rapidly rising burden of diabetes and peripheral vascular disease, and expanding endovascular access across China, India, Japan, and Southeast Asia. Growing healthcare investment and increasing numbers of trained interventionalists are broadening adoption of peripheral vascular devices.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth market. A rising burden of diabetes and vascular disease, expanding endovascular care, and growing healthcare investment are broadening adoption from a developing base, while Latin American manufacturers such as Braile Biomedica contribute to the region.

Peripheral Vascular Devices Market Competitive Landscape

The Peripheral Vascular Devices market is classified as Consolidated. A small number of large multinational manufacturers, including Medtronic, Boston Scientific, Abbott, and Becton Dickinson, hold significant combined share across the major device categories, alongside Cook Medical, B. Braun, W. L. Gore and Associates, Terumo, AngioDynamics, and LeMaitre Vascular, together with numerous smaller specialized and emerging companies focused on specific device niches. The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Consolidated, with a few large multinationals holding significant combined share alongside numerous smaller specialized companies.
• Leading players: Medtronic, Boston Scientific, Abbott, and Becton Dickinson lead across major device categories, with Cook Medical, B. Braun, W. L. Gore, Terumo, AngioDynamics, and LeMaitre Vascular prominent.
• Geographic reach: Leading players operate globally, with the strongest presence in North America and Europe and expanding activity in Asia-Pacific.
• Product portfolio strength: Players hold broad portfolios spanning balloon catheters, stents, atherectomy and thrombectomy systems, embolic protection, chronic total occlusion devices, and inferior vena cava filters.
• Pipeline strength: Active development in next-generation drug-coated balloons, drug-eluting stents, mechanical thrombectomy, and advanced atherectomy and crossing devices.
• Strategic partnerships: Collaborations with interventional specialists, hospitals, and research institutions, and clinical trial programs shape the landscape.
• M&A and investment activity: The field has seen notable acquisitions, including consolidation of atherectomy and mechanical thrombectomy technologies, alongside ongoing investment.
• Manufacturing and technology capabilities: Drug-coating, stent, catheter, and thrombectomy engineering are key competitive differentiators.
• Innovation focus: Drug-coated balloons, drug-eluting stents, large-bore mechanical thrombectomy, advanced atherectomy, and complex-lesion and venous intervention technologies.

Peripheral Vascular Devices Market Recent Developmental Activities

In 2023 and 2024, Medtronic continued to market and develop its peripheral vascular portfolio, including the IN. PACT Admiral drug-coated balloon and peripheral stent and atherectomy offerings.PACT Admiral drug-coated balloon and peripheral stent and atherectomy offerings. Strategic significance: Sustains leadership across drug-coated balloon and peripheral intervention segments.

In 2023 and 2024, Boston Scientific advanced its peripheral interventions portfolio, including the Ranger drug-coated balloon, Eluvia drug-eluting stent, and atherectomy and thrombectomy systems. Strategic significance: Reinforces a broad peripheral and venous intervention franchise.

Peripheral Vascular Devices Market Segmentation

Peripheral Vascular Devices Market by Product Type

• Percutaneous Transluminal Angioplasty Balloon Catheters (Drug-Eluting, Cutting, Scoring)
• Angioplasty Stents (Drug-Eluting, Bare-Metal, Expandable)
• Plaque Modification Devices (Atherectomy, Thrombectomy)
• Hemodynamic Flow Alteration Devices (Embolic Protection, Chronic Total Occlusion)
• Inferior Vena Cava Filters (Retrievable, Permanent)
• Others

Peripheral Vascular Devices Market by Application

• Peripheral Artery Disease
• Deep Vein Thrombosis and Venous Thromboembolism
• Pulmonary Embolism
• Others

Peripheral Vascular Devices Market by End User

• Hospitals
• Specialty Centers
• Others

Peripheral Vascular Devices Market by Geography

• North America Peripheral Vascular Devices Market
• United States Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Canada Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Mexico Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Europe Peripheral Vascular Devices Market
• Germany Peripheral Vascular Devices Market Size in USD million (2023-2034)
• United Kingdom Peripheral Vascular Devices Market Size in USD million (2023-2034)
• France Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Italy Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Spain Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Rest of Europe Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Asia-Pacific Peripheral Vascular Devices Market
• China Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Japan Peripheral Vascular Devices Market Size in USD million (2023-2034)
• India Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Australia Peripheral Vascular Devices Market Size in USD million (2023-2034)
• South Korea Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Rest of the World (RoW) Peripheral Vascular Devices Market
• Middle East Peripheral Vascular Devices Market Size in USD million (2023-2034)
• Africa Peripheral Vascular Devices Market Size in USD million (2023-2034)
• South America Peripheral Vascular Devices Market Size in USD million (2023-2034)

Key Takeaways from the Peripheral Vascular Devices Market Report Study

• Market size analysis for the current peripheral vascular devices market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global peripheral vascular devices market.
• Various opportunities available for competitors in the peripheral vascular devices market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current peripheral vascular devices market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for peripheral vascular devices market growth in the future?

Target audience who can benefit from this peripheral vascular devices market report study

• Peripheral Vascular Devices manufacturers and product providers
• Research organizations and consulting companies
• Peripheral Vascular Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in peripheral vascular devices
• Various end-users who want to know more about the peripheral vascular devices market and the latest technological developments in the peripheral vascular devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the Peripheral Vascular Devices market?

The Peripheral Vascular Devices market is projected to expand at a CAGR of 5.92% during the forecast period of 2026-2034.

Q2. What is the market size of the Peripheral Vascular Devices market?

The Peripheral Vascular Devices market is estimated at USD 10.44 billion in 2025 and is projected to reach USD 17.5 billion by 2034.

Q3. Which region dominates the Peripheral Vascular Devices market?

North America dominated the Peripheral Vascular Devices market with a 41% share of global revenue in 2025, supported by a high burden of peripheral vascular disease, advanced endovascular infrastructure, high procedure volumes, early adoption of innovative devices, favorable reimbursement, and the presence of major manufacturers. Asia-Pacific is the fastest-growing region over the forecast period, driven by large aging and diabetic populations and expanding endovascular access.

Q4. What are the key drivers of the Peripheral Vascular Devices market?

The principal drivers are the large and rising burden of peripheral artery disease; the aging global population; the growing diabetic and at-risk population; and continued innovation in drug-eluting and advanced endovascular devices, reinforced by the shift toward minimally invasive endovascular procedures and the rising burden of venous thromboembolism.

Q5. Who are the major players in the Peripheral Vascular Devices market?

The major players include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Becton, Dickinson and Company (BD), Cook Group Incorporated (Cook Medical), B. Braun SE, W. L. Gore & Associates, Inc., Terumo Corporation, AngioDynamics, Inc., and LeMaitre Vascular, Inc., among other active manufacturers profiled in the Competitive Landscape section. The market is consolidated, with a few large multinationals holding significant combined share alongside numerous smaller specialized companies.